The 50-day moving average for KYKOF moved below the 200-day moving average on December 02, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 22 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Aroon Indicator for KYKOF entered a downward trend on November 29, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Momentum Indicator moved above the 0 level on December 10, 2024. You may want to consider a long position or call options on KYKOF as a result. In of 38 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
KYKOF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.925) is normal, around the industry mean (5.632). P/E Ratio (29.326) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.004). Dividend Yield (0.020) settles around the average of (0.164) among similar stocks. P/S Ratio (3.654) is also within normal values, averaging (3.643).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. KYKOF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KYKOF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.
Industry PharmaceuticalsMajor
A.I.dvisor tells us that KYKOF and OPHLY have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KYKOF and OPHLY's prices will move in lockstep.
Ticker / NAME | Correlation To KYKOF | 1D Price Change % | ||
---|---|---|---|---|
KYKOF | 100% | N/A | ||
OPHLY - KYKOF | 12% Poorly correlated | -1.41% | ||
NVSEF - KYKOF | 7% Poorly correlated | N/A | ||
GIKLY - KYKOF | 4% Poorly correlated | +2.19% | ||
MAYNF - KYKOF | -1% Poorly correlated | -0.50% | ||
HAWPF - KYKOF | -1% Poorly correlated | N/A | ||
More |